Ixabepilone (epothilone B analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: A Southwest Oncology Group Trial S0111

Maha Hussain, Catherine M. Tangen, Primo N. Lara, Ulka N. Vaishampayan, Daniel P. Petrylak, A. Dimitrios Colevas, Wael A. Sakr, E. David Crawford

Research output: Contribution to journalArticlepeer-review

139 Scopus citations

Fingerprint

Dive into the research topics of 'Ixabepilone (epothilone B analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: A Southwest Oncology Group Trial S0111'. Together they form a unique fingerprint.

Medicine & Life Sciences